🇺🇸 Budesonide/formoterol Turbuhaler in United States
6 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 6
Most-reported reactions
- Expired Drug Administered — 2 reports (33.33%)
- Product Quality Issue — 2 reports (33.33%)
- Device Failure — 1 report (16.67%)
- Device Malfunction — 1 report (16.67%)
Other Respiratory approved in United States
Frequently asked questions
Is Budesonide/formoterol Turbuhaler approved in United States?
Budesonide/formoterol Turbuhaler does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Budesonide/formoterol Turbuhaler in United States?
AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.